American society of clinical oncology road to recovery report: Learning from the covid-19 experience to improve clinical research and cancer care

Nathan A. Pennell, Melissa Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai S. Alva, Sibel Blau, Timothy L. Cannon, Natalie R. Dickson, Maximilian Diehn, Mithat Gonen, Maria Magdalena Gonzalez, Jack O. Hensold, Leslie J. Hinyard, Tari King, Stacie C. Lindsey, Allison Magnuson, Jonathan Marron, Barbara L. McAneny, Theresa M. McDonnell, Kathryn Finch MilehamShelley Fuld Nasso, Grzegorz S. Nowakowski, Kurt R. Oettel, Manali I. Patel, Debra A. Patt, Jane Perlmutter, Todd A. Pickard, Gladys Rodriguez, Abby R. Rosenberg, Barry Russo, Connie Szczepanek, Cardinale B. Smith, Piyush Srivastava, Eleonora Teplinsky, Ramya Thota, Tiffany A. Traina, Robin Zon, Brian Bourbeau, Suanna S. Bruinooge, Shelagh Foster, Stephen Grubbs, Karen Hagerty, Patricia Hurley, Deborah Kamin, Jonathan Phillips, Caroline Schenkel, Richard L. Schilsky, Howard A. Burris

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving forward as the pandemic recedes. ASCO organized its recommendations for clinical research around five goals to ensure lessons learned from the COVID-19 experience are used to craft a more equitable, accessible, and efficient clinical research system that protects patient safety, ensures scientific integrity, and maintains data quality. The specific goals are: (1) ensure that clinical research is accessible, affordable, and equitable; (2) design more pragmatic and efficient clinical trials; (3) minimize administrative and regulatory burdens on research sites; (4) recruit, retain, and support a well-trained clinical research workforce; and (5) promote appropriate oversight and review of clinical trial conduct and results. Similarly, ASCO also organized its recommendations regarding cancer care delivery around five goals: (1) promote and protect equitable access to high-quality cancer care; (2) support safe delivery of high-quality cancer care; (3) advance policies to ensure oncology providers have sufficient resources to provide high-quality patient care; (4) recognize and address threats to clinician, provider, and patient well-being; and (5) improve patient access to high-quality cancer care via telemedicine. ASCO will work at all levels to advance the recommendations made in this report.

Original languageEnglish (US)
Pages (from-to)155-169
Number of pages15
JournalJournal of Clinical Oncology
Volume39
Issue number2
DOIs
StatePublished - Jan 10 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'American society of clinical oncology road to recovery report: Learning from the covid-19 experience to improve clinical research and cancer care'. Together they form a unique fingerprint.

Cite this